{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-095068","form_type":"8-K","ticker":"SXTP","cik":"0001946563","company_name":"60 DEGREES PHARMACEUTICALS, INC.","filed_at":"2024-11-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.407645+00:00","generated_at":"2026-05-30T04:52:25.788346+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Shareholders approve reverse stock split, warrant exercise, and equity plan increase at special meeting","bullets":["Proposal to approve exercise of warrants for up to 6,014,493 shares passed with 259,282 for, 14,312 against.","Amendment to 2022 Equity Incentive Plan to increase shares by 500,000 approved: 253,106 for, 21,172 against.","Reverse stock split authorization (ratio 1:3 to 1:5) approved: 675,553 for, 77,032 against.","Adjournment proposal also approved: 674,854 for, 77,335 against.","Meeting held Nov 6, 2024; quorum of ~40.7% voting shares represented."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-095068","json":"https://secwatch.observer/filing/0001213900-24-095068.json","markdown":"https://secwatch.observer/filing/0001213900-24-095068.md","text":"https://secwatch.observer/filing/0001213900-24-095068.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1946563/000121390024095068/0001213900-24-095068-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1946563/000121390024095068/ea022027801-8k_60degrees.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T04:52:25.788346+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}